Kotyark Industries Ltd.

•
₹ 37.332.92%

2026-08-21

kotyark.comBSE: 544726NSE: KOTYARK
Market Cap₹ 393 Cr.
Current Price₹ 36
High / Low₹ 46 / 17
Stock P/E20.9
Book Value₹ 25
Price to Book2.29
Dividend Yield1.31 %
ROCE15.4 %
ROE11.3 %
Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

PROS

  • Company maintains a comfortable, low leverage position

CONS

  • Operating cash flow has been negative in recent years
  • Receivables are growing faster than sales - a possible quality concern
  • Promoter holding has decreased over last 2 years: -11.8pp
  • Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.20x)
  • Valuation is stretched - P/E of 20.9 is well above its own 5-year median (2.0)
  • Operating margins have contracted to 15.2% from 18.8%

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

EDIT COLUMNS
Fast Moving Consumer GoodsAgriAgriculture
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.NameCMP Rs.P/EMar Cap Rs.Cr.Div Yld %NP Qtr Rs.Cr.Qtr Profit Var %Sales Qtr Rs.Cr.Qtr Sales Var %ROCE %OPM %
1.KSCL768.9015.853955.150.00279.84-14.47742.50-13.5121.7739.58
2.VENKEYS1502.25308.042116.270.6749.99215.791118.3829.1711.276.18
3.AVTNPL87.1515.841327.160.9231.10156.69241.2282.1614.2616.56
4.REGAAL97.080.00999.860.2613.3346.95202.15-18.0216.9115.33
5.BSHSL88.720.00931.000.0014.3016.56182.5719.3721.199.39
6.KOTYARK34.7720.94393.151.319.38—63.66—15.3730.08
7.NATHBIOGEN154.007.99292.661.3032.26-13.46328.4015.766.8910.70
8.INDOUS86.2034.14172.850.003.04-35.3832.997.2121.1512.01
9.MSL145.0019.15159.210.003.971.9361.8425.8112.349.28
10.OSWALSEEDS13.309.96121.660.0012.2768.60117.0819.539.8815.65
11.NARMADA14.440.00110.770.007.54—222.63—8.944.25
12.AGRITECH101.300.0060.170.00-3.6161.180.00—-1.10—
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2022
36
29
Operating Profit
—
OPM %
—
Other Income
0
Interest
0
Depreciation
0
6
Tax %
24.54%
Net Profit
4
5
Equity Capital
9
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
9
Reserves
0
Promoter Pledge %
0.00%
Mar 2025
20
14
Operating Profit
—
OPM %
—
Other Income
0
Interest
2
Depreciation
4
0
Tax %
-235.56%
Net Profit
0
1
Equity Capital
10
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
10
Reserves
0
Promoter Pledge %
0.00%
Mar 2026
64
45
Operating Profit
—
OPM %
—
Other Income
0
Interest
2
Depreciation
3
14
Tax %
30.93%
Net Profit
9
9
Equity Capital
10
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
10
Reserves
0
Promoter Pledge %
0.00%

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023
131
106
Operating Profit
25
OPM %
19
Other Income
0
Interest
3
Depreciation
2
19
Tax %
26
Net Profit
14
EPS
15
Dividend Payout %
30
Minority Interest
0
Share of Associates
0
Adjusted EPS
1
Minority Interest
0
Share of Associates
0
Adjusted EPS
1
Mar 2024
271
227
Operating Profit
45
OPM %
17
Other Income
1
Interest
7
Depreciation
8
31
Tax %
27
Net Profit
22
EPS
22
Dividend Payout %
35
Minority Interest
0
Share of Associates
0
Adjusted EPS
2
Minority Interest
0
Share of Associates
0
Adjusted EPS
2
Mar 2025
288
245
Operating Profit
43
OPM %
15
Other Income
1
Interest
8
Depreciation
15
20
Tax %
29
Net Profit
15
EPS
14
Dividend Payout %
60
Minority Interest
-0
Share of Associates
0
Adjusted EPS
1
Minority Interest
-0
Share of Associates
0
Adjusted EPS
1
Mar 2026
315
267
Operating Profit
48
OPM %
15
Other Income
0
Interest
8
Depreciation
13
27
Tax %
28
Net Profit
19
EPS
18
Dividend Payout %
27
Minority Interest
-1
Share of Associates
0
Adjusted EPS
2
Minority Interest
-1
Share of Associates
0
Adjusted EPS
2

COMPOUNDED SALES GROWTH

10 Years:
—
5 Years:
—
3 Years:
34%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
—
3 Years:
9%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
-10%
1 Year:
-5%

RETURN ON EQUITY

10 Years:
—
5 Years:
—
3 Years:
14%
Last Year:
11%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2026

Jun 24

10:1

Bonus Issue Inter alia, to consider and approve:- 1) To consider and approve increase in Authorised Share Capital of the Company and consequent alteration to the Memorandum of Association of the Company, subject to approval of the shareholders of the Company and such other regulatory/statutory approvals as may be required. 2) To recommend and approve the proposal for issue of Bonus Shares to the existing Equity Shareholders of the Company, subject to approval of the shareholders of the Company and such other regulatory/statutory approvals as may be required. 3)To transact any other business with the permission of the Chairman.

Mar 2023
Equity Capital
9
67
18
Trade Payables
0
22
Total Liabilities
115
26
Capital Work in Progress
8
37
0
Cash & Bank
0
44
Total Assets
115
Total Debt
34
Net Working Capital
38
Contingent Liabilities
0
Book Value per Share
86.78
Face Value
10.00
Total Debt
34
Net Working Capital
38
Contingent Liabilities
0
Book Value per Share
86.78
Face Value
10.00
Mar 2024
Equity Capital
10
134
28
Trade Payables
0
50
Total Liabilities
222
74
Capital Work in Progress
8
85
34
Cash & Bank
5
16
Total Assets
222
Total Debt
68
Net Working Capital
91
Contingent Liabilities
0
Book Value per Share
140.21
Face Value
10.00
Total Debt
68
Net Working Capital
91
Contingent Liabilities
0
Book Value per Share
140.21
Face Value
10.00
Mar 2025
Equity Capital
10
152
19
Trade Payables
12
41
Total Liabilities
235
67
Capital Work in Progress
13
128
10
Cash & Bank
0
16
Total Assets
235
Total Debt
50
Net Working Capital
107
Contingent Liabilities
0
Book Value per Share
157.72
Face Value
10.00
Total Debt
50
Net Working Capital
107
Contingent Liabilities
0
Book Value per Share
157.72
Face Value
10.00
Mar 2026
Equity Capital
10
170
37
Trade Payables
1
41
Total Liabilities
260
57
Capital Work in Progress
13
151
18
Cash & Bank
1
19
Total Assets
260
Total Debt
65
Net Working Capital
126
Contingent Liabilities
0
Book Value per Share
175.83
Face Value
10.00
Total Debt
65
Net Working Capital
126
Contingent Liabilities
0
Book Value per Share
175.83
Face Value
10.00

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023
10
Cash from Investing
-32
Cash from Financing
22
-0
Free Cash Flow
10
OCF / Net Profit
0.69
Cumulative 5-Year FCF
0
OCF / Net Profit
0.69
Cumulative 5-Year FCF
0
Mar 2024
-16
Cash from Investing
-53
Cash from Financing
74
5
Free Cash Flow
-71
OCF / Net Profit
-0.70
Cumulative 5-Year FCF
0
OCF / Net Profit
-0.70
Cumulative 5-Year FCF
0
Mar 2025
31
Cash from Investing
-13
Cash from Financing
-22
-5
Free Cash Flow
18
OCF / Net Profit
2.13
Cumulative 5-Year FCF
0
OCF / Net Profit
2.13
Cumulative 5-Year FCF
0
Mar 2026
-4
Cash from Investing
-3
Cash from Financing
8
1
Free Cash Flow
-6
OCF / Net Profit
-0.20
Cumulative 5-Year FCF
0
OCF / Net Profit
-0.20
Cumulative 5-Year FCF
0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023
EPS (₹)
16.42
Book Value (₹)
86.78
Dividend per Share (₹)
5.00
Cash EPS (₹)
1.70
Operating Margin %
18.78%
Net Margin %
10.95%
ROE %
18.93%
ROCE %
20.47%
12.46%
Debtor Days
38
Inventory Days
102
Payable Days
0
140
Debt to Equity (x)
0.45x
Interest Coverage (x)
6.86x
2.74x
Revenue Growth %
0.00%
Operating Profit Growth %
0.00%
Net Profit Growth %
0.00%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2024
EPS (₹)
21.60
Book Value (₹)
140.21
Dividend per Share (₹)
7.50
Cash EPS (₹)
2.69
Operating Margin %
16.42%
Net Margin %
8.19%
ROE %
20.19%
ROCE %
23.02%
13.18%
Debtor Days
32
Inventory Days
82
Payable Days
0
114
Debt to Equity (x)
0.47x
Interest Coverage (x)
5.67x
2.98x
Revenue Growth %
106.88%
Operating Profit Growth %
84.60%
Net Profit Growth %
54.75%
31.50%
P/E (x)
56.08x
P/B (x)
8.64x
Dividend Yield %
0.62%
28.80x
Mar 2025
EPS (₹)
14.08
Book Value (₹)
157.72
Dividend per Share (₹)
8.50
Cash EPS (₹)
2.63
Operating Margin %
14.80%
Net Margin %
5.04%
ROE %
9.49%
ROCE %
13.27%
6.37%
Debtor Days
28
Inventory Days
135
Payable Days
10
153
Debt to Equity (x)
0.31x
Interest Coverage (x)
3.64x
3.50x
Revenue Growth %
6.31%
Operating Profit Growth %
-4.43%
Net Profit Growth %
-34.53%
-34.83%
P/E (x)
2.01x
P/B (x)
1.97x
Dividend Yield %
2.74%
8.50x
Mar 2026
EPS (₹)
18.26
Book Value (₹)
175.83
Dividend per Share (₹)
5.00
Cash EPS (₹)
2.85
Operating Margin %
15.22%
Net Margin %
6.15%
ROE %
11.30%
ROCE %
15.37%
7.84%
Debtor Days
16
Inventory Days
162
Payable Days
10
168
Debt to Equity (x)
0.36x
Interest Coverage (x)
4.23x
3.22x
Revenue Growth %
9.29%
Operating Profit Growth %
10.56%
Net Profit Growth %
33.24%
29.74%
P/E (x)
2.01x
P/B (x)
2.29x
Dividend Yield %
1.24%
9.96x

Shareholding Pattern

Numbers in percentages

TRADES
Mar 2023
69.17
0.00
1.01
Government
0.00
29.67
Sep 2023
69.17
0.00
0.00
Government
0.00
30.83
Mar 2024
67.65
0.94
0.60
Government
0.00
30.81
Sep 2024
67.65
0.94
0.56
Government
0.00
30.85
Mar 2025
67.76
1.06
0.00
Government
0.00
31.18
Sep 2025
67.76
1.06
0.00
Government
0.00
31.18
Dec 2025
66.88
1.03
0.00
Government
0.00
32.10
Mar 2026
63.84
1.03
0.00
Government
0.00
35.13
Jun 2026
57.34
0.10
0.00
Government
0.00
42.56

Documents

Announcements

  • Dividend

    2026-08-13 - Kotyark Industries Limited has informed the Exchange that Board of Directors at its meeting held on April 27, 2026, recommended Final Dividend of Rs. 5 per equity share with reference to the pre-bonus share capital corresponds to ₹0.4545 per Equity Share on the post-bonus share capital

  • Reasons for Delayed/Non-submission of Financial Results

    2026-08-13 - Kotyark Industries Limited has informed the Exchange about reasons for Delayed submission of Financial Results for the end of Quarter June 30, 2026

Annual Reports

Credit Ratings

Nothing filed yet.

Concalls

  • Jun 2026

    TranscriptPPTREC

  • May 2026

    TranscriptPPTREC

  • May 2025

    TranscriptPPTREC